Billionaire investor Mark Cuban has firmly ruled out a presidential bid while throwing his weight behind a partnership with the Trump administration aimed at driving down prescription drug prices for Americans.
According to Fox News, Cuban dismissed speculation about a White House run during an appearance on "Fox & Friends," stating bluntly, "It's not going to happen," when asked about entering the 2024 race. He instead described a different ambition: "My dream has not been to be president, but my dream, and truly, as an entrepreneur, I think I can have an impact and really change the economics of healthcare in this country. I think that's something that can have as big an impact as any political position."
Speaking to Fox News' Steve Doocy during a live morning walk in Pittsburgh, Cuban outlined how he intends to align his private-sector initiative with TrumpRx, the Trump administrations program designed to link U.S. consumers with lower-cost medications. "We're working really close with TrumpRx," he shared, underscoring a rare point of bipartisan cooperation centered on affordability rather than ideology.
Cuban owns CostPlusDrugs.com, a direct-to-consumer prescription platform that bypasses pharmacy benefit managers (PBMs) and other intermediaries widely criticized for inflating prices. He stressed that the universal appeal of cheaper drugs means Republicans, Democrats and independents like himself can unite behind efforts to reduce costs without partisan rancor.
"We're going to be integrating our list of medications there. We're looking to bring manufacturing from overseas for generics to Dallas, so there's so many things we're doing with the administration that I think will really accelerate [cost reduction]," he added, highlighting a reshoring strategy that aligns with conservative priorities of domestic production and economic self-reliance. Cuban said the broader mission is straightforward: make every element of maintaining good health affordable, beginning with prescription drugs and then extending "across the board" to the entire healthcare system.
He detailed how his model is already disrupting the pharmaceutical marketplace, explaining that prices are built from a basic manufacturing cost, a 15% markup to sustain operations, a $5 pharmacy labor fee and roughly $5 for shipping. "You can save a lot of money, particularly if you have cancer, multiple sclerosis, [or] kidney disease," he said, pointing to patients facing some of the highest drug bills.
"There's a lot of really expensive drugs out there that, because we only mark it up 15%, we can save people hundreds if not thousands of dollars per month and we've really changed people's lives, and that's important to me at this time." In an era when big-government healthcare schemes dominate the lefts agenda, Cubans collaboration with President Trumps team showcases a market-driven, limited-government approach that seeks to harness competition, transparency and American manufacturing to deliver tangible relief to patients.
Login